Le Lézard
Classified in: Business

Reunion Neuroscience Inc. to Commence Trading on the Toronto Stock Exchange on August 17, 2022

TORONTO, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Reunion Neuroscience Inc. (formerly, Field Trip Health Ltd., the "Company" or "Reunion"), a global leader in the discovery and development of innovative of psychedelic-inspired therapeutics for improved mental health outcomes, is pleased to announce that its common shares (the "Shares") will commence trading on the Toronto Stock Exchange ("TSX") under the ticker symbol "REUN" at the opening of the market on August 17, 2022.

Trading of the Company's shares on the TSX represents the last step in the corporate reorganization that resulted in the spinout of the Company's former subsidiary, Field Trip Health & Wellness Ltd. ("FTHW") into a stand-alone public company listed on the TSX Venture Exchange. Reunion continues to hold a 21.84% interest in FTHW.

For further details on the business of the Company, please refer to the management information circular dated May 20, 2022 and the supplement thereto available on its SEDAR and EDGAR profiles available at www.sedar.com or https://www.sec.gov/edgar.

About Reunion Neuroscience Inc., (formerly, Field Trip Health Ltd.)

Reunion is a leader in novel psychedelic drug development, committed to innovating therapeutic solutions for mental health conditions by developing proprietary serotonin receptor agonist compounds. The Company's lead asset, RE-104 (previously known as FT-104), is a proprietary, novel psychedelic drug being developed for post-partum and treatment resistant depression as a potential fast-acting antidepressant with durable efficacy. Reunion is also developing the FT-200 series, which includes compounds with potential for more selective serotonin receptor activity with reduced psychoactivity for potential use in more chronic treatment paradigms and indications.

Learn more at https://www.investors.reunionneuro.com, and https://www.reunionneuro.com.

Follow us on Twitter and Instagram: @reunionneuro.

Cautionary Note Regarding Forward-Looking Information 

This release includes forward-looking information (within the meaning of Canadian securities laws and within the meaning of the United States Private Securities Litigation Reform Act of 1995) regarding the Company and its business. Often but not always, forward-looking information can be identified by the use of words such as "expect", "intends", "anticipated", "believes" or variations (including negative variations) of such words and phrases, or state that certain actions, events or results "may", "could", "would" or "will" be taken, occur or be achieved. Such statements are based on the current expectations and views of future events of the management of the Company and are based on assumptions and subject to risks and uncertainties. Although the management of believes that the assumptions underlying these statements are reasonable, they may prove to be incorrect. The forward-looking events and circumstances discussed in this release may not occur and could differ materially as a result of known and unknown risk factors and uncertainties affecting the companies. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended. Accordingly, readers should not place undue reliance on any forward-looking statements or information. No forward-looking statement can be guaranteed. Except as required by applicable securities laws, forward-looking statements speak only as of the date on which they are made and the Company does not undertake any obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise. Additional information relating to Field Trip, including its Annual Information Form, can be located on the SEDAR website at www.sedar.com and on the EDGAR section of the SEC's website at www.sec.gov.

Neither Toronto Stock Exchange, or its Regulation Services Provider, have approved the contents of this release or accept responsibility for the adequacy or accuracy of this release.


Reunion Neuroscience:
Joseph del Moral
[email protected]

Media contacts:
McKenna Miller / Nick Opich
KCSA Strategic Communications
[email protected]

Investor contacts:
Phil Carlson / Sophia Bashford
KCSA Strategic Communications
[email protected]

SOURCE Reunion Neuroscience Inc.


These press releases may also interest you

at 16:30
The national workforce development organization Year Up announced that it has promoted Ellen McClain to President to lead Year Up as it pursues the next phase of its growth strategy, focusing on increasing access to opportunity for young adults and...

at 16:30
Precision Optics Corporation, Inc. , a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, announced operating results on an unaudited basis for its fourth quarter and fiscal year ended June 30,...

at 16:20
AXIS Capital Holdings Limited ("AXIS Capital" or the "Company") today announced that it expects to release financial results for the third quarter ended September 30, 2022 on Wednesday, October 26, 2022 after the close of the financial markets....

at 16:20
Hancock Whitney Corporation will announce third quarter 2022 financial results on Tuesday, October 18, 2022 after the market closes. Management will host a conference call for analysts and investors at 4:00 p.m. Central Time on Tuesday, October 18,...

at 16:15
The tourism and hospitality sector is a key economic driver and job creator, especially for young Canadians. That is why the Government of Canada is taking action to help youth prepare for careers in this growing part of the economy.   Today, to mark...

at 16:15
MAA  today announced that its board of directors approved a quarterly dividend payment of $1.25 per share of common stock to be paid on October 31, 2022, to shareholders of record on October 14, 2022....

News published on 16 august 2022 at 12:50 and distributed by: